Wearable Metabolic Sensor for Monitoring of Lactate and Glucose for People with Diabetes
Award amount
$853,587Program and phase
SBIR · Phase IIAward year
2025Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Biolinq Incorporated
- Proposal award date
- 2025-06-15
- Contract end date
- 2028-05-31
- UEI
- GW6NF3RJFSH8
- Solicitation number
- PA23-230
- Topic code
- NIDDK
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- A Hybrid Continuous Glucose and Lactate Monitor with Improved Signal Reliability
- A Hybrid Continuous Glucose and Lactate Monitor with Improved Signal Reliability
- Wearable Biosensors for Real time Blood Alcohol Monitoring
- Wearable Biosensors for Real-time Blood Alcohol Monitoring
- Microneedle-based Transdermal Sensing of Electrolytes: Towards A Metabolic Panel-
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- ND Enabling Studies for CMT-101, a Novel Gene Therapy for Glycogen Storage Disease 1b
- Novel Over-the-Scope Platform for Control of Variceal Bleeding
- Tolerogenic Nanotherapy to Delay Type I Diabetes
- An intravascular Bioartificial Pancreas (iBAP)
- Preclinical Development of a Therapeutic Antibody for Type-1 Diabetes
Research funding history
7 SBIR/STTR records share this UEI (2014–2025). Reported award amounts total $4,907,636. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services